38148-63-9 Usage
Description
4-Hydroxybenzamidine hydrochloride is an organic compound that exists as a white crystalline solid. It is a derivative of benzamidine with an additional hydroxyl group at the para position, which imparts unique chemical properties and reactivity to the molecule.
Uses
Used in Pharmaceutical Industry:
4-Hydroxybenzamidine hydrochloride is used as a pharmaceutical intermediate for the synthesis of various drugs and medicinal compounds. Its unique chemical structure allows it to be a versatile building block in the development of new pharmaceuticals, particularly those targeting specific biological pathways or receptors.
Used in Organic Chemical Synthesis:
In addition to its pharmaceutical applications, 4-Hydroxybenzamidine hydrochloride is also utilized in organic chemical synthesis. Its reactivity and functional groups make it a valuable component in the creation of a wide range of organic compounds, including those with potential applications in various industries such as materials science, agrochemicals, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 38148-63-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,4 and 8 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 38148-63:
(7*3)+(6*8)+(5*1)+(4*4)+(3*8)+(2*6)+(1*3)=129
129 % 10 = 9
So 38148-63-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O.ClH/c8-7(9)5-1-3-6(10)4-2-5;/h1-4,10H,(H3,8,9);1H
38148-63-9Relevant articles and documents
Synthesis and anti cervical cancer activity of novel 5H-thiochromeno [4,3-d]pyrimidines
Naliapara, Yogesh,Pandya, Dhananjay
, p. 294 - 302 (2020/04/21)
A series of novel 5H-Thiochromeno[4,3-d]pyrimidine derivatives were synthesized, purified and characterized by different spectroscopy techniques such as1H NMR,13C NMR, Mass and Elemental Analysis. The new compounds were evaluated for their anti-cervical cancer activity on Human Cervical Cell Line HeLa. They were found to be potent anti-cervical cancer agents with GI50 values less than 10 μg/mL with respect to positive control drug Adriamycin.